SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel.

Annapaola SantoroAndrea CapriDaniele PetroneFrancesca ColavitaSilvia MeschiGiulia MatusaliKlizia MizzoniStefania NotariChiara AgratiDelia Goletti Patrizio Pezzotti Vincenzo Puro

Published in: Biomedicines (2023)

Routine testing for vaccine-induced humoral immune response to SARS-CoV-2 is not recommended if measured as parameters of 'protective immunity' from SARS-CoV-2 after vaccination. Whether these findings apply to new Omicron-specific bivalent vaccines is going to be evaluated.

Keyphrases

sars cov
immune response
respiratory syndrome coronavirus
high glucose
coronavirus disease
drug induced
diabetic rats
emergency department
clinical practice
adverse drug
binding protein